Langerhans Cell Histiocytosis Treatment - Changes to the Summary (09�/�30�/�2011)
The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.
This summary was comprehensively reviewed and extensively revised.
Cellular Classification of Pheochromocytoma and Paraganglioma
Pathologic Classification Pheochromocytoma and paraganglioma characteristically form small nests of uniform polygonal chromaffin cells ("zellballen"). A diagnosis of malignancy can only be made by identifying tumor deposits in tissues that do not normally contain chromaffin cells (e.g., lymph nodes, liver, bone, lung, and other distant metastatic sites). Regional or distant metastatic disease is documented on initial pathology in only 3% to 8% of patients; thus, an attempt has been made...
Read the Cellular Classification of Pheochromocytoma and Paraganglioma article > >
WebMD Public Information from the National Cancer Institute
Langerhans Cell Histiocytosis Treatment Topics
- General Information About Langerhans Cell Histiocytosis (LCH)
- Childhood LCH
- Histopathologic, Immunologic, and Cytogenetic Characteristics of LCH
- Presentation of LCH in Children
- Diagnostic Evaluation of Childhood LCH
- Follow-up Considerations in Childhood LCH
- Treatment of Childhood LCH
- Treatment of Recurrent, Refractory, or Progressive Childhood LCH
Today in Cancer
WebMD Special Sections
Health Solutions From Our Sponsors
©2005-2013 WebMD, LLC. All rights reserved.
WebMD does not provide medical advice, diagnosis or treatment. See additional information.